Resolution of refractory no-reflow with intracoronary epinephrine

Catheterization and Cardiovascular Interventions

Volumn 57, Issue 3, 2002, Pages 305-309

  Skelding, Kimberly A ^a   Goldstein, James A ^a   Mehta, Laxmi ^a   Pica, Mark C ^a   O'Neill, William W ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Angioplasty; Complications; Percutaneous coronary intervention; Saphenous vein graft

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLYCERYL TRINITRATE; HEPARIN; UROKINASE; VERAPAMIL;

ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY STENT; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HEART RATE; HEART RHYTHM; HUMAN; HYPOTENSION; RETROSPECTIVE STUDY; SAPHENOUS VEIN GRAFT; SYSTOLIC BLOOD PRESSURE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE DISEASE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; COMBINED MODALITY THERAPY; CORONARY CIRCULATION; CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EPINEPHRINE; HEART RATE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INTRA-AORTIC BALLOON PUMPING; MICHIGAN; NITROGLYCERIN; RETROSPECTIVE STUDIES; SYNDROME; SYSTOLE; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS; VERAPAMIL;

EID: 0036842286     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10303     Document Type: Article

References (28)

1. Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, Carrozza JP, Kuntz RE, Baim DS. Incidence and treatment of "no-reflow" after percutaneous coronary intervention. Circulation 1994;89:2514-2518.
2. Abbo KM, Dooris M, Glazier S, O'Neill WW, Byrd D, Grines CL, Safian RD. Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol 1995;75:778-782.
3. Watson PS, Hadjipetrou, P, Cox SV, Pyne CT, Gossman DE, Piemonte TC, Eisenhauer AC. Angiographic and clinical outcomes following acute infarct angioplasty on saphenous vein grafts. Am J Cardiol 1999;83:1018-1020.
4. Marzilli M, Gliozheni E, Marriaccino P, Fedele S. Primary coronary angioplasty in acute myocardial infarction: Clinical correlates of the "no-reflow" phenomenon. Int J Cardiol 1998;65:S23-S28.
5. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Masatsugu H, Higashino Y, Fujii K, Minamino T. Clinical implications of the "no-reflow" phenomenon: A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infraction. Am Heart J 1996;93:223-228.
6. Weyrens FJ, Mooney J, Lesser J, Mooney MR. Intracoronary diltiazem for microvascular spasm after interventional therapy. Am J Cardiol 1995;75:849-850.
7. Kitazume H, Iwama T, Kubo I, Ageishi Y, Suzuki A. No-reflow phenomenon during percutaneous transluminal coronary angioplasty. Am Heart J 1988;116:211-215.
8. Hashimoto K, Hashimoto K. Cardiac irregularities induced by intracoronary injection of epinephrine and acetylcholine into various portions of the canine ventricle. Am Heart J 1972;83:197-205.
9. Marzilli M, Orsini E, Marraccini P, Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 2000;101:2154-2159.
10. McIvor ME, Undemir C, Lawson J, Reddinger J. Clinical effects and utility of intracoronary diltiazem. Cathet Cardiovasc Diagn 1995;35:287-291.
11. Kaplan BM, Benzuli KH, Kinn JW, Bowers TR, Tilli FV, Grines CL, O'Neill WW, Safian RD. Treatment of no-reflow in degenerated saphenous vein graft interventions: Comparison of intracoronary verapamil and nitroglycerine. Cathet Cardiovasc Diagn 1996;39:113-118.
12. Sdringola S, Assali A, Ghani M, Yepes A, Rosales O, Schroth GW, Fujise K, Anderson HV, Smalling RW. Adenosine use during aortocoronary vein graft interventions reverses but does not prevent the slow-no-reflow phenomenon. Cathet Cardiovasc Intervent 2000;51:394-399.
13. Assal AR, Sdringola S, Ghani M, Denkats AE, Yepes A, Hanna GP, Schroth G, Fujise K, Anderson HV, Smalling RW, Rosales OR. Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of "no-reflow" phenomenon. Cathet Cardiovasc Intervent 2000;51:27-31.
14. Hanna GP, Yhip P, Fujise K, Schroth GW, Rosales OR, Anderson HV, Smalling RW. Intracoronary adenosine administered during rotational atherectomy of complex lesions in native coronary arteries reduces the incidence of no-reflow phenomenon. Cathet Cardiovasc Intervent 1999;48:275-278.
15. Ishihara M, Sato H, Tateishi H, Kawagoe T, Shimatani Y, Kurisu S, Kakai K. Attenuation of the no-reflow phenomenon after coronary angioplasty for acute myocardial infarction with intracoronary papaverine. Am Heart J 1996;132:959-963.
16. Rawitscher D, Levin TN, Cohen I, Feldman T. Rapid reversal of no-reflow using abciximab after coronary device intervention. Cathet Cardiovasc Diagn 1997;42:187-190.
17. Cohen BM, Weber VJ, Blum RR, Ruck BE, Cohen DE, Haik BJ, Coletti RH. Cocktail attenuation of rotational ablation flow effects (CARAFE) study: pilot. Cathet Cardiovasc Diagn 1996;3(Suppl): 69-72.
18. Carlino M, De Gregorio J, Di Mario C, Anzuini A, Airoldi F, Albiero R, Briguiori C, Dharmadhikari A, Sheiban I, Columbo A. Prevention of distal embolization during saphenous vein graft lesion angioplasty. Circulation 1999;99:3221-3223.
19. Webb JG, Carere RG, Virmani R, Baim D, Teirstein PS, Whitlow P, McQueen C, Kolodgie FD, Buller E, Dodek A, Mancini GBJ, Oesterle S. Retrieval and analysis of particulate debris after saphenous vein graft intervention. J Am Coll Cardiol 1999;34:468-475.
20. Van Houtte PM. Heterogeneity in vascular smooth muscle. In: Kaley G, Altura BM, editors. Microcirculation, vol. 2. University Park Press; 1978. p 181-309.
21. Hoffmann BB, Lefkowitz RJ. Catecholamines, sympathomimetic drugs and adrenergic receptor antagonists. In: Molinoff PB, Ruddon RW, editors. Goodman and Gilman's Pharmacologic Basis of Therapeutics, 9th Ed. New York: McGraw-Hill; 1996. p 199-248.
22. Cornett LE. The Adrenal Medulla. In: Patton HD, Fuchs AF, Hille B, Schler AM, Steiner R, editors. Textbook of Physiology, 21st Ed., vol. 2. Philadelphia: W.B. Saunders; 1989. p 1229-1238.
23. Gavin JB, Maxwell L, Edgar SG. Microvascular involvement in cardiac pathology. J Mol Cell Cardiol 1998;30:2531-2540.
24. Stein BC, Moses J, Teirstein PS. Balloon occlusion and transluminal aspiration of saphenous vein grafts to prevent distal embolization. Cathet Cardiovasc Intervent 2000;51:69-73.
25. Shaknovich A, Forman ST, Parikh MA, Deutsch E, Bergman GW, McCaffrey TA, Newman GC, Tarazona N, Sanborn TA. Novel distal occluder washout method for prevention of no-reflow during stenting of saphenous vein grafts. Cathet Cardiovasc Intervent 1999;47:397-403.
26. Trimarco B, Cuocolo A, Ricciardelli B, Patrignani P, Volpe M, DeLuca N, Condorelli M. Effects of prostaglandin synthesis inhibition on sympathetic and parasympathetic mediated coronary hemodynamic responses. J Pharm Exp Therap 1985;237:589599.
27. Yorikane R, Kanda A, Kimura T, Satoh S. Effects of epinephrine, isoproterenol, and IPS-339 on sympathetic transmission to the dog heart: Evidence against the facilitory role of presynaptic beta adrenoreceptors. J. Pharm Exp Therap 1985:238:334-340.
28. Kahn JK, Hartzler GO, Reversal of refractory hypotension with intracoronary epinephrine during coronary angioplasty. Am Heart J 1993;126:463-466.